Inner Mitochondrial Membrane Latching for Rapid ATP Restoration

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Aging is driven by the combination of mutations and incorrect methylation of mitochondrial and nuclear DNA, leading to reduced ATP output and associated diseases, with existing methods being slow and ineffective in addressing epimutations.

Innovation Solution

The use of up-latching and down-latching protocols and supplements, including carboxylic acids and their salts, to rapidly modify the inner mitochondrial membrane (IMM) and increase or decrease ATP output, combined with biogenesis promoters and UCP2 blockers to enhance mitochondrial energetics.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If mitochondrial quality control (PINK1/Parkin) is used to address mtDNA mutations, then mutated mitochondria can be labeled and degraded, but it responds poorly against epimutations (methylation) and cannot eliminate methylation marks

Engineering Contradiction:
Improvemitochondrial quality control effectivenessVSAvoidability to address epimutations
Core Design Contradiction:
ReliabilityVSAdaptability or versatility

Solution Approach 1:

The patent extracts the methylation marks from mtDNA through demethylase enzymes, separating and removing the harmful epimutation component from the mitochondrial genome. This allows the PINK1/Parkin QC system to focus on mutations while the demethylase handles methylation, dividing the QC function into two specialized pathways.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces demethylase enzymes as intermediary agents that mediate between the methylation problem and the QC system. These enzymes act as intermediaries that convert methylated mtDNA into unmethylated mtDNA, enabling the existing PINK1/Parkin pathway to effectively address both mutation and methylation issues.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Productivity

If ATP output is increased to combat aging, then mitochondrial energetics improve, but existing methods are slow and cannot rapidly restore youthful levels

Engineering Contradiction:
ImproveATP outputVSAvoidtime to restore mitochondrial health
Core Design Contradiction:
ProductivityVSLoss of time

Solution Approach 1:

The patent applies preliminary action by first removing methylation marks through demethylase enzymes before and during the ATP generation process. This preliminary demethylation step prepares the mtDNA for optimal function, allowing subsequent ATP production to proceed at maximum speed and efficiency, thereby rapidly restoring youthful energy levels.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent changes the chemical parameter of mtDNA by removing methyl groups through demethylase activity. This parameter change (de-methylation) fundamentally alters the transcriptional output of mitochondrial genes, enabling rapid upregulation of OXPHOS complexes and swift restoration of high ATP output levels.

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If methylation of mtDNA is reduced to improve ATP production, then OXPHOS complex production increases, but existing approaches are ineffective against epimutations

Engineering Contradiction:
ImproveOXPHOS complexesVSAvoideffectiveness against epimutations
Core Design Contradiction:
Quantity of substanceVSReliability

Solution Approach 1:

The patent enables self-service by using the cell's own demethylase enzymes to remove methylation marks from mtDNA. This self-service mechanism allows the mitochondria to autonomously correct their own epimutations without external intervention, naturally increasing OXPHOS complex production and improving ATP generation.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent changes the epigenetic parameter of mtDNA by removing methyl groups, thereby altering gene expression patterns. This parameter change (demethylation) directly increases the transcription and translation of OXPHOS complex subunits, leading to higher complex quantities and improved mitochondrial function.

Inventive Principle:
Principle #35Parameter changes

4Power

If up-latching of the inner mitochondrial membrane is performed to increase ATP output, then mitochondrial energetics are enhanced, but the mechanism is novel and requires specific carboxylic acid supplements

Engineering Contradiction:
ImproveATP outputVSAvoidsupplement protocol complexity
Core Design Contradiction:
PowerVSDevice complexity

Solution Approach 1:

The patent changes the physical-chemical parameter of the inner mitochondrial membrane by introducing carboxylic acid supplements that modify membrane fluidity and permeability. This parameter change enables up-latching of the membrane, allowing increased density of OXPHOS complexes and swift enhancement of ATP output power.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

Rapid restoration of ATP output to youthful levels, improving athletic performance and reducing the severity of age-related diseases by eliminating methylation marks and promoting symmetric stem cell division.

Implementation Method 1

Plasticizers are used to increase the concentration of oxidative phosphorylation complexes present in the inner mitochondrial membrane

Methodology Applied
Scientific EffectPlasticization: Plasticity

Implementation Method 2

A proton gradient across the IMM is created by complexes that pump protons from the matrix into the intermembrane space

Methodology Applied
Scientific EffectProton pumping: Pump

Implementation Method 3

The return flow of protons through another embedded IMM complex-ATP synthase-produces adenosine triphosphate (ATP)

Methodology Applied
Scientific EffectChemical energy conversion: Chemical Bonding

Implementation Method 4

PINK1/Parkin proteins that label mitochondria with zero surface potential

Methodology Applied
Scientific EffectElectrostatic labeling: Electrostatics

Data Source

PatentUS20250221952A1Methods and compositions for large modifications of ATP output by inner mitochondrial membrane latching
Publication Date: 2025.07.10 DISCHLER LOUIS
  • US20250221952A1 patent drawing
  • US20250221952A1 patent drawing
  • US20250221952A1 patent drawing

AI summary

Disclosed are methods and antiaging compositions for the rapid restoration of mitochondrial health by demethylation, the dramatic modification of ATP output by up-latching or down-latching of the inner mitochondrial membrane, and the rapid elimination of symptoms due to mitochondrial dysfunction.